TY  - JOUR

T1  - Targeting tumour-initiating cells with TRAIL based combination therapy ensures complete and lasting eradication of multiple myeloma tumours in vivo.

JO  - PLoS One

PY  - 2012/05/16

AU  - Vitovski S

AU  - Chantry AD

AU  - Lawson MA

AU  - Croucher PI

ED  - 

DO  - DOI: 10.1371/journal.pone.0035830

VL  - 7

IS  - 5

SP  - e35830

Y2  - 2025/11/15

ER  -